Enterprise Value
344.8M
Cash
50.22M
Avg Qtr Burn
-11.36M
Short % of Float
0.98%
Insider Ownership
31.87%
Institutional Own.
52.36%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|